These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 39142667)

  • 1. SARS-CoV-2 Dynamics in the Premier League Testing Program, United Kingdom.
    Kucharski AJ; Russell TW; Hellewell J; Funk S; Steele A; Edmunds WJ; Gillett M
    Emerg Infect Dis; 2024 Sep; 30(9):1975-1977. PubMed ID: 39142667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Warning Surveillance for SARS-CoV-2 Omicron Variants, United Kingdom, November 2021-September 2022.
    Foulkes S; Monk EJM; Sparkes D; Hettiarachchi N; Milligan ID; Munro K; Taylor-Kerr A; Platt N; Howells A; Kyaw JYA; Adaji E; Gallagher E; Khawam J; Wellington E; Price L; Crossman D; Norman C; de Lacy E; Cromey L; Corrigan D; Lackenby A; Barbero P; Elegunde B; Zambon M; Chand MA; Brown CS; Islam J; Atti A; Hopkins S; Hall VJ; Cole MJ;
    Emerg Infect Dis; 2023 Jan; 29(1):184-188. PubMed ID: 36454718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study.
    Graham MS; Sudre CH; May A; Antonelli M; Murray B; Varsavsky T; Kläser K; Canas LS; Molteni E; Modat M; Drew DA; Nguyen LH; Polidori L; Selvachandran S; Hu C; Capdevila J; ; Hammers A; Chan AT; Wolf J; Spector TD; Steves CJ; Ourselin S
    Lancet Public Health; 2021 May; 6(5):e335-e345. PubMed ID: 33857453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Adoption of Longitudinal Surveillance for SARS-CoV-2 among Staff in Long-Term Care Facilities: Prevalence, Virologic and Sequence Analysis.
    Gallichotte EN; Quicke KM; Sexton NR; Fitzmeyer E; Young MC; Janich AJ; Dobos K; Pabilonia KL; Gahm G; Carlton EJ; Ebel GD; Ehrhart N
    Microbiol Spectr; 2021 Dec; 9(3):e0100321. PubMed ID: 34756092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020-2022.
    Teran RA; Gagner A; Gretsch S; Lauritsen J; Galanto D; Walblay K; Ruestow P; Korban C; Pacilli M; Kern D; Black SR; Tabidze I
    Emerg Infect Dis; 2023 Nov; 29(11):2257-2265. PubMed ID: 37877555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal Admission Screening for SARS-CoV-2 Infections among Hospitalized Patients, Switzerland, 2020.
    Scheier T; Schibli A; Eich G; Rüegg C; Kube F; Schmid A; Karrer U; Wolfensberger A; Sax H; Schreiber PW
    Emerg Infect Dis; 2021 Feb; 27(2):404-410. PubMed ID: 33395382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roll-out of SARS-CoV-2 testing for healthcare workers at a large NHS Foundation Trust in the United Kingdom, March 2020.
    Keeley AJ; Evans C; Colton H; Ankcorn M; Cope A; State A; Bennett T; Giri P; de Silva TI; Raza M
    Euro Surveill; 2020 Apr; 25(14):. PubMed ID: 32290904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reinfection cases by closely related SARS-CoV-2 lineages in Southern Brazil.
    Gularte JS; da Silva MS; Demoliner M; Hansen AW; Heldt FH; Silveira F; Filippi M; Pereira VMAG; da Silva FP; Mallmann L; Fink P; Laux JL; Weber MN; de Almeida PR; Fleck JD; Spilki FR
    Braz J Microbiol; 2021 Dec; 52(4):1881-1885. PubMed ID: 34562232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk for International Importations of Variant SARS-CoV-2 Originating in the United Kingdom.
    Du Z; Wang L; Yang B; Ali ST; Tsang TK; Shan S; Wu P; Lau EHY; Cowling BJ; Meyers LA
    Emerg Infect Dis; 2021 May; 27(5):1527-1529. PubMed ID: 33760727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory Viral Shedding in Healthcare Workers Reinfected with SARS-CoV-2, Brazil, 2020.
    Amorim MR; Souza WM; Barros ACG; Toledo-Teixeira DA; Dos-Santos KB; Simeoni CL; Parise PL; Vieira A; Forato J; Claro IM; Mofatto LS; Barbosa PP; Brunetti NS; França ESS; Pedroso GA; Carvalho BFN; Zaccariotto TR; Krywacz KCS; Vieira AS; Mori MA; Farias AS; Pavan MHP; Bachur LF; Cardoso LGO; Spilki FR; Sabino EC; Faria NR; Santos MNN; Angerami R; Leme PAF; Schreiber A; Moretti ML; Granja F; Proenca-Modena JL
    Emerg Infect Dis; 2021; 27(6):1737-1740. PubMed ID: 33871331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom.
    Tyson GB; Jones S; Logan N; McDonald M; Marshall L; Murcia PR; Willett BJ; Weir W; Hosie MJ
    Emerg Infect Dis; 2023 Jun; 29(6):1223-1227. PubMed ID: 37141617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First documented reinfection of SARS-COV-2 in second wave from Pakistan.
    Ul-Haq Z; Khan A; Fazid S; Noor F; Yousafzai YM; Sherin A
    J Ayub Med Coll Abbottabad; 2020; 32(Suppl 1)(4):S704-S705. PubMed ID: 33754536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study design.
    Ayoub HH; Tomy M; Chemaitelly H; Altarawneh HN; Coyle P; Tang P; Hasan MR; Al Kanaani Z; Al Kuwari E; Butt AA; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Nasrallah GK; Benslimane FM; Al Khatib HA; Yassine HM; Al Kuwari MG; Al Romaihi HE; Abdul-Rahim HF; Al-Thani MH; Al Khal A; Bertollini R; Abu-Raddad LJ
    Am J Epidemiol; 2024 Jun; 193(6):883-897. PubMed ID: 38061757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses.
    Mutnal MB; Arroliga AC; Walker K; Mohammad A; Brigmon MM; Beaver RM; Midturi JK; Rao A
    J Med Virol; 2020 Oct; 92(10):2130-2138. PubMed ID: 32410236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad respiratory testing to identify SARS-CoV-2 viral co-circulation and inform diagnostic stewardship in the COVID-19 pandemic.
    Marshall NC; Kariyawasam RM; Zelyas N; Kanji JN; Diggle MA
    Virol J; 2021 May; 18(1):93. PubMed ID: 33933115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic evidence of SARS-CoV-2 reinfection in the Republic of Korea.
    Park AK; Rhee JE; Kim IH; Kim HM; Lee H; Kim JA; Lee CY; Lee NJ; Woo S; Lee J; No JS; Rhie GE; Wang SJ; Lee SE; Park YJ; Park G; Kim JY; Gwack J; Yoo CK; Kim EJ
    J Med Virol; 2022 Apr; 94(4):1717-1722. PubMed ID: 34862628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of COVID-19 reinfection in the UK.
    West J; Everden S; Nikitas N
    Clin Med (Lond); 2021 Jan; 21(1):e52-e53. PubMed ID: 33303623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early SARS-CoV-2 Reinfections within 60 Days and Implications for Retesting Policies.
    Nevejan L; Cuypers L; Laenen L; Van Loo L; Vermeulen F; Wollants E; Van Hecke I; Desmet S; Lagrou K; Maes P; André E
    Emerg Infect Dis; 2022 Aug; 28(8):1729-1731. PubMed ID: 35738346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Characterization of COVID-19 Patients with Repeatedly Positive SARS-CoV-2 Tests Using a Large U.S. Electronic Health Record Database.
    Dong X; Zhou Y; Shu XO; Bernstam EV; Stern R; Aronoff DM; Xu H; Lipworth L
    Microbiol Spectr; 2021 Sep; 9(1):e0032721. PubMed ID: 34406805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United Kingdom.
    Vihta KD; Pouwels KB; Peto TEA; Pritchard E; Eyre DW; House T; Gethings O; Studley R; Rourke E; Cook D; Diamond I; Crook D; Matthews PC; Stoesser N; Walker AS;
    Clin Infect Dis; 2022 Aug; 75(1):e329-e337. PubMed ID: 34748629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.